The classes of antiretroviral therapy drugs attack the HIV virus at various points in the duplication process to prevent it from making copies of itself. Taking an ART cocktail of drugs from ...

A pioneering study at UKZN has demonstrated that 20% of HIV patients in the trial remained off antiretroviral therapy while ...

the pool of cells that harbor the sleeping virus that can prevent ART from curing HIV." With regards to how the bNAbs control ...

The study aimed to reduce traces of HIV in the body and help the immune system fight the virus without chronic medication.

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

The trial conducted in Durban, South Africa, showed that 20 per cent of participants remain off ART and are virally suppressed after one-and-a-half years, according to a press statement from the ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Antiretroviral therapy (ART) can keep HIV suppressed indefinitely, but the virus inserts its genetic blueprints into host cells and establishes a long-lasting reservoir that is nearly impossible to ...

HIV is a virus that attacks cells in the body fighting off infections ... Tracking HIV persistence across T cell lineages ...